NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)

Active Not RecruitingN/A

Sponsor: Regeneron Pharmaceuticals

Conditions: Dermatitis, Atopic

Interventions: Dupilumab

Countries: United States, Canada

A long-term observational registry in patients with atopic dermatitis (AD) initiating treatment with DUPIXENT® (dupilumab)

Eligibility overview

Sex: ALL

Age: 12 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Key Inclusion Criteria:

* Male or female, 12 years of age or older at the baseline visit. NOTE: Adolescent patients (at least 12 years old, but less than 18 years) are eligible in the US or Canada only after DUPIXENT receives the respective country's regulatory approval for use in this age group.
* Initiating treatment with DUPIXENT® as standard-of-care for AD according to the country-specific prescribing information (Note: Participants will be screened when they received their initial prescription for DUPIXENT®).
* Willing and able to comply with study-related activities.
* Able to understand and complete study-related questionnaires.
* Provide signed informed consent or parental/legal guardian consent plus patient assent, where applicable.

Key Exclusion Criteria:

* Patients who have a contraindication to the drug according to the country-specific prescribing information label.
* Any condition that, in the opinion of the investigator, may interfere with patient's ability to participate in the study, such as short life expectancy, substance abuse, severe cognitive impairment, or other co-morbidities that can predictably prevent the patient from adequately completing the schedule of visits and assessments.
* Prior use of dupilumab within 6 months of the screening visit, or within 6 months of the baseline visit if screening and baseline occur on the same day.

NOTE: Other protocol defined Inclusion/Exclusion criteria apply.

Locations (99)

Birmingham, Alabama, United States
Gilbert, Arizona, United States
Fountain Valley, California, United States
Laguna Hills, California, United States
Loma Linda, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
Manhattan Beach, California, United States
Newport Beach, California, United States
Oceanside, California, United States
Redondo Beach, California, United States
Riverside, California, United States
Roseville, California, United States
San Diego, California, United States
Santa Monica, California, United States
Thousand Oaks, California, United States
New Haven, Connecticut, United States
Coral Gables, Florida, United States
Margate, Florida, United States
West Palm Beach, Florida, United States
Atlanta, Georgia, United States
Macon, Georgia, United States
Marietta, Georgia, United States
Marietta, Georgia, United States
Sandy Springs, Georgia, United States
Champaign, Illinois, United States
Chicago, Illinois, United States
La Grange Park, Illinois, United States
Skokie, Illinois, United States
Springfield, Illinois, United States
+ 69 more on CT.gov